IRLAB Reports Progress Ahead of Mesdopetam Phase III Program
29 Oct 2024 //
ACCESSWIRE
IRLAB Receives End-of-Ph 2 Meeting Confirming Alignment with the FDA
22 Mar 2024 //
ACCESSWIRE
IRLAB Provides Update on Mesdopetam`s Phase IIb Study Data
21 Aug 2023 //
ACCESSWIRE
IRLAB reports LPLV Achieved in Phase IIb Clinical Study of Mesdopetam
14 Dec 2022 //
ACCESSWIRE
IRLAB Completes Recruitment in Phase IIb Study of Mesdopetam (IRL790)
12 Sep 2022 //
ACCESSWIRE
IRLAB`s partner Ipsen Initiates Clinical Studies in Line with Mesdopetam`s DevP
05 Sep 2022 //
ACCESSWIRE